Global Colloids Blood Plasma Market Poised for Substantial Growth Through 2033

Rising Demand for Volume Expansion Therapies Drives Market Evolution

The global colloids blood plasma market is experiencing unprecedented growth, driven by increasing surgical procedures, rising chronic disease prevalence, and expanding therapeutic applications in critical care medicine. The colloids blood plasma market was valued at approximately USD 5.1 billion in 2023, with projections for growth to USD 9.2 billion by 2033, representing a CAGR of 6.0% from 2024 to 2033.

Get a free sample report: https://datahorizzonresearch.com/request-sample-pdf/colloids-blood-plasma-market-4246

Understanding Colloids in Blood Plasma

Colloids represent a critical component of modern medical therapy, functioning as volume expanders that maintain blood pressure and circulation during critical medical situations. The liquid portion of whole blood, which makes up to 60% of the total blood volume and contains proteins including serum fibrinogen, albumins, and globulins, is known as colloids (blood plasma). These sophisticated solutions offer superior volume expansion capabilities compared to traditional crystalloid alternatives.

Market Segments and Applications

Product Categories

The market encompasses two primary segments:

Natural Type Colloids: Including human albumin solutions, fresh frozen plasma, and plasma protein fractions that leverage naturally occurring blood components for therapeutic applications.

Synthetic Type Colloids: Comprising hydroxyethyl starches, gelatins, and dextrans designed to replicate the beneficial properties of natural plasma proteins while offering enhanced stability and availability.

Therapeutic Applications

The market serves diverse medical applications:

Extensive Burns: Volume replacement for patients experiencing significant fluid loss
Massive Blood or Plasma Loss: Emergency interventions during traumatic injuries and surgical procedures
Hypovolemic Shock: Critical care management for patients experiencing dangerous drops in blood volume
Surgical Procedures: Routine volume maintenance during elective and emergency operations
Surgeries often require volume replacement to maintain blood pressure and circulation, whether elective or emergency. Colloids are preferred in surgical settings due to their rapid plasma volume expansion capabilities.

Ask for a discount: https://datahorizzonresearch.com/ask-for-discount/colloids-blood-plasma-market-4246

Key Market Drivers

Growing Surgical Volume

The September 2020 research report titled "Estimation of the National Surgical Needs in India by Enumerating the Surgical Procedures in an Urban Community Under Universal Health Coverage" projected that over 11% of the global disease burden necessitated surgical or anesthetic treatment. This expanding surgical landscape directly correlates with increased demand for effective volume expansion solutions.

Chronic Disease Epidemic

The prevalence of chronic diseases significantly influences the colloids market for blood plasma products. Chronic conditions like cardiovascular diseases, kidney disorders, and liver ailments often lead to complications that require volume expansion and stabilization through colloids. The Centers for Disease Control and Prevention (CDC) estimate that 6 out of 10 individuals in America have one or more chronic illnesses, and that 4 out of 10 persons have two or more.

Innovation in Plasma-Derived Therapeutics

The need for plasma-derived medicines, including as immunoglobulins, albumin, and factor VIII, to treat a range Primary immunodeficiency illnesses, autoimmune disorders, and haemophilia are among the problems that are treated with plasma-derived treatments. This diversification of applications continues to expand market opportunities.

Leading Industry Players

The colloids blood plasma market features several established pharmaceutical companies driving innovation and market expansion:

CSL Behring: A global leader in plasma-derived and recombinant therapies with extensive research and development capabilities.

Grifols: Specializing in plasma medicines with a comprehensive portfolio of albumin and immunoglobulin products.

Octapharma: Focusing on human proteins from human plasma and human cell lines for therapeutic use.

Biotest: Developing and marketing immunoglobulins, albumin, and coagulation products derived from human plasma.

Kedrion: Manufacturing plasma-derived therapeutics for treating rare and severe diseases globally.

These companies have invested heavily in research and development and are constantly innovating to produce new and improved products.

Recent Market Developments

Regulatory Approvals and Product Launches

In May 2020, Bio Products Laboratory (BPL), a prominent producer of plasma-derived protein therapies, introduced ALBUMINEX 5% (human albumin) solution for injection and ALBUMINEX 25% (human albumin) solution for injection in the US. These products received FDA approval for treating multiple conditions including hypovolemia, burns, and acute respiratory distress syndrome.

In July 2023, Kedrion Biopharma, a global biopharmaceutical company that focuses on manufacturing and distributing plasma-derived therapeutic products for the treatment of rare and severe diseases, announced that China's National Institutes for Food and Drug Control (NIFDC) had approved for the release of BPL's human Albumin product in the Chinese market.

Regional Market Analysis

North America Dominance

North America is estimated to hold the largest colloids (blood plasma) market share due to several factors including advanced healthcare infrastructure, high surgical volumes, and strong regulatory frameworks supporting product development and adoption.

Asia-Pacific Growth Potential

The Asia-Pacific region represents significant growth opportunities driven by expanding healthcare systems, increasing surgical procedures, and growing awareness of advanced treatment options for critical care management.

Market Outlook and Future Trends

Technology Integration

The market is witnessing increased integration of advanced manufacturing technologies and quality control systems to ensure product safety and efficacy. Enhanced purification processes and synthetic alternatives are expanding treatment options while addressing supply chain challenges.

Supply Chain Optimization

The global market for colloids was already facing a shortage of supply prior to the pandemic. With the pandemic, the demand is now much greater. Industry stakeholders are implementing strategic initiatives to optimize plasma collection, processing, and distribution networks.

Safety and Efficacy Focus

Ongoing research continues to refine colloid formulations, addressing historical concerns about allergic reactions and side effects while maximizing therapeutic benefits for patients requiring volume expansion therapy.

Challenges and Opportunities

Market Challenges

The industry faces several challenges including regulatory complexity, supply chain constraints, and the need for specialized storage and handling requirements. Additionally, competition from alternative volume expansion therapies requires continuous innovation and differentiation.

Growth Opportunities

Emerging markets present substantial growth opportunities as healthcare infrastructure develops and access to advanced therapies expands. The increasing prevalence of chronic diseases and aging populations worldwide create sustained demand for effective volume expansion solutions.

Conclusion

The global colloids blood plasma market stands at a pivotal juncture, with robust growth projections supported by fundamental demographic and medical trends. As surgical procedures increase globally and chronic disease management becomes increasingly sophisticated, the demand for effective volume expansion therapies continues to accelerate. Leading industry players are well-positioned to capitalize on these trends through continued innovation, strategic expansion, and commitment to patient safety and therapeutic efficacy.

The market's evolution reflects broader trends in modern medicine toward personalized, evidence-based treatments that improve patient outcomes while optimizing healthcare resource utilization. With strong regulatory support, advancing technology, and expanding global access to healthcare, the colloids blood plasma market is positioned for sustained growth and continued therapeutic advancement.

Contact:
Ajay N
Ph: +1-970-672-0390

Latest Reports:

https://datahorizzonresearch.com/industrial-capsaicin-market-32969
https://datahorizzonresearch.com/industrial-camera-for-machine-vision-market-32970
https://datahorizzonresearch.com/industrial-caliper-disc-brake-market-32971
https://datahorizzonresearch.com/industrial-caliper-brakes-market-32972
https://datahorizzonresearch.com/industrial-cable-ties-market-32973
https://datahorizzonresearch.com/industrial-carbohydrase-market-32968
https://datahorizzonresearch.com/industrial-bromobutyl-rubber-market-32975
https://datahorizzonresearch.com/industrial-bromine-market-32976
https://datahorizzonresearch.com/industrial-breathing-set-scba-market-32977
https://datahorizzonresearch.com/industrial-breakaway-coupling-market-32978
https://datahorizzonresearch.com/industrial-ct-scanning-services-market-32979
https://datahorizzonresearch.com/industrial-coupling-market-32980
https://datahorizzonresearch.com/industrial-counterweights-market-32981
https://datahorizzonresearch.com/industrial-cotton-spinning-machine-market-32982
https://datahorizzonresearch.com/industrial-cords-market-32983
https://datahorizzonresearch.com/open-surgery-heart-valves-market-32984
https://datahorizzonresearch.com/industrial-controlled-atmosphere-furnaces-market-32985
https://datahorizzonresearch.com/industrial-contactor-market-32986
https://datahorizzonresearch.com/industrial-concrete-flooring-market-32987
https://datahorizzonresearch.com/industrial-computed-radiography-market-32988
https://datahorizzonresearch.com/industrial-compressor-oil-market-32989
https://datahorizzonresearch.com/industrial-combustible-gas-alarm-market-32990
https://datahorizzonresearch.com/industrial-cold-storage-market-32991
https://datahorizzonresearch.com/industrial-coil-coatings-market-32992
https://datahorizzonresearch.com/industrial-coating-resins-market-32993
https://datahorizzonresearch.com/industrial-co2-refrigeration-compressors-market-32994
https://datahorizzonresearch.com/industrial-cnc-vertical-honing-machine-market-32995
https://datahorizzonresearch.com/industrial-climbing-gear-market-32996
https://datahorizzonresearch.com/industrial-dimethyl-disulphide-market-32997
https://datahorizzonresearch.com/industrial-digital-twin-market-32998
https://datahorizzonresearch.com/industrial-digital-detonator-market-32999
https://datahorizzonresearch.com/industrial-dextrins-market-33000
https://datahorizzonresearch.com/industrial-design-clay-market-33001
https://datahorizzonresearch.com/industrial-deodorizer-market-33002
https://datahorizzonresearch.com/industrial-demolition-service-market-33003
https://datahorizzonresearch.com/industrial-delta-robot-market-33004
https://datahorizzonresearch.com/industrial-defrosting-equipment-market-33005
https://datahorizzonresearch.com/industrial-defoamers-market-33006
https://datahorizzonresearch.com/industrial-decanter-centrifuge-market-33007
https://datahorizzonresearch.com/industrial-dataops-platform-market-33008
https://datahorizzonresearch.com/industrial-cyclone-separator-market-33009
https://datahorizzonresearch.com/industrial-cyclone-market-33010
https://datahorizzonresearch.com/industrial-cyclone-dust-collector-market-33011
https://datahorizzonresearch.com/industrial-cyclohexylamine-market-33012
https://datahorizzonresearch.com/industrial-cyclohexane-market-33013
https://datahorizzonresearch.com/industrial-dry-vacuum-pumps-market-33014
https://datahorizzonresearch.com/industrial-drums-market-33015
https://datahorizzonresearch.com/industrial-drone-services-market-33016
https://datahorizzonresearch.com/industrial-draft-tube-crystallizer-market-33017
https://datahorizzonresearch.com/industrial-double-disc-grinding-machine-market-33018

Company Name: DataHorizzon Research
Address: North Mason Street, Fort Collins,
Colorado, United States.
Ph: +1-970-672-0390

DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR's comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.

This release was published on openPR.